SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001445305-13-002940
Filing Date
2013-11-12
Accepted
2013-11-12 11:19:01
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q navb930201310q.htm 10-Q 727244
2 EXHIBIT 3.2 navb9302013ex3-2.htm EX-3.2 95281
3 EXHIBIT 31.1 navb9302013ex31-1.htm EX-31.1 9917
4 EXHIBIT 31.2 navb9302013ex31-2.htm EX-31.2 9913
5 EXHIBIT 32.1 navb9302013ex32-1.htm EX-32.1 5169
6 EXHIBIT 32.2 navb9302013ex32-2.htm EX-32.2 5218
  Complete submission text file 0001445305-13-002940.txt   4770107

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT navb-20130930.xml EX-101.INS 497339
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT navb-20130930.xsd EX-101.SCH 32942
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT navb-20130930_cal.xml EX-101.CAL 53369
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT navb-20130930_def.xml EX-101.DEF 158707
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT navb-20130930_lab.xml EX-101.LAB 469269
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT navb-20130930_pre.xml EX-101.PRE 277097
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35076 | Film No.: 131208487
SIC: 2835 In Vitro & In Vivo Diagnostic Substances